Skip to main content
    K

    Kodiak Sciences Inc (KOD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $100.73
    -10.46 (-9.41%)

    Market Cap: $7.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Kodiak Sciences Inc (KOD) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Kodiak Sciences reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$229.97M, operating cash flow was -$136.01M and free cash flow was -$136.51M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$66.22M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $234.39M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0N/AN/AN/AN/A
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0N/AN/AN/AN/A
    Dec 2016$0N/AN/AN/AN/A
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Research and development$182.37M$126.09M$206.30M$267.59M$217.34M$107.39M$37.51M$18.79M$22.02M$14.05M
    Operating income-$234.39M-$186.85M-$277.32M-$341.38M-$267.05M-$136.01M-$49.19M-$26.37M-$25.52M-$17.15M
    Net income-$229.97M-$176.21M-$260.49M-$333.82M-$266.99M-$133.10M-$47.37M-$41.44M-$27.94M-$17.13M
    EBITDA-$208.16M-$160.65M-$252.11M-$330.89M-$258.45M-$131.83M-$48.26M-$25.09M-$25.07M-$16.87M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$0$0$0$26.65M$0$0$0$0
    Gross profit$0$0$0$19.80M$0$0$0-$6.68M$0$0$0-$6.66M
    Operating income-$67.10M-$66.84M-$59.78M-$57.45M-$62.35M-$55.51M-$59.07M-$46.18M-$46.63M-$47.98M-$46.05M-$63.37M
    Net income-$66.22M-$65.64M-$58.16M-$56.74M-$61.46M-$54.31M-$57.46M-$44.10M-$43.95M-$45.12M-$43.04M-$59.52M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $13.56M by $196.30M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$351.53M$335.58M$479.37M$666.63M$904.22M$1.07B$358.87M$92.19M$3.24M$12.11M
    Current assets$214.82M$171.94M$289.31M$486.00M$734.81M$972.00M$339.23M$90.45M$1.59M$10.19M
    Cash and equivalents$209.86M$168.07M$285.51M$190.43M$731.51M$944.40M$211.80M$88.25M$1.40M$9.62M
    Total liabilities$194.15M$185.29M$213.59M$230.46M$240.90M$206.60M$13.51M$5.36M$21.96M$53.20M
    Short-term debt$12.06M$10.63M$9.77M$9.93M$3.93M$2.37M$434.00KN/A$108.00K$82.00K
    Long-term debt$1.50MN/AN/AN/AN/AN/AN/AN/A$9.92M$103.00K
    Shareholder equity$157.38M$150.29M$265.78M$436.17M$663.32M$860.75M$345.36M$86.83M-$68.74M-$41.08M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$209.41M$256.81M$306.01M$351.53M$218.07M$256.73M$297.91M$335.58M$372.67M$401.58M$434.76M$479.37M
    Total liabilities$196.84M$195.72M$193.91M$194.15M$194.38M$186.44M$189.07M$185.29M$187.30M$187.07M$193.57M$213.59M
    Cash and equivalents$88.68M$125.90M$169.53M$209.86M$72.04M$104.17M$138.85M$168.07M$197.86M$219.22M$245.92M$285.51M
    Shareholder equity$12.57M$61.10M$112.10M$157.38M$23.69M$70.29M$108.84M$150.29M$185.37M$214.51M$241.19M$265.78M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$136.01M-$117.32M-$154.18M-$206.46M-$182.27M-$83.43M-$39.15M-$29.03M-$17.66M-$16.05M
    Capital expenditures$506.00K$375.00K$41.35M$37.02M$17.03M$3.81M$437.00K$78.00K$209.00K$771.00K
    Free cash flow-$136.51M-$117.69M-$195.53M-$243.48M-$199.30M-$87.24M-$39.58M-$29.11M-$17.86M-$16.82M
    Dividends paidN/AN/AN/A$7.91M$10.04M$6.25M$2.29MN/AN/AN/A
    Share repurchasesN/AN/AN/AN/AN/AN/AN/AN/AN/A$4.00K
    Investing cash flow-$506.00K-$755.00K$249.23M-$336.51M-$38.80M$104.83M-$137.00M-$581.00K-$209.00K-$771.00K
    Financing cash flow$178.30M$501.00K$31.00K$1.90M$8.18M$717.38M$299.69M$116.47M$9.64M-$120.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$43.87M-$46.24M-$40.01M-$39.38M-$32.88M-$34.67M-$29.08M-$30.07M-$21.16M-$26.49M-$39.60M-$32.24M
    Capital expenditures$1.98M$352.00K$942.00K$43.00K$60.00K$133.00K$270.00K$124.00K$180.00K$49.00K$22.00K$27.48M
    Free cash flow-$45.84M-$46.59M-$40.95M-$39.42M-$32.94M-$34.81M-$29.35M-$30.19M-$21.34M-$26.54M-$39.62M-$59.72M
    Last 12 quarters

    Frequently Asked Questions About KOD

    What is Kodiak Sciences' annual revenue?

    Kodiak Sciences reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Kodiak Sciences profitable?

    No. Kodiak Sciences reported net income of -$229.97M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does KOD generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$136.01M minus capital expenditures of $506.00K produced free cash flow of -$136.51M.

    How much debt does Kodiak Sciences have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.50M, short-term debt of $12.06M and cash and equivalents of $209.86M.